An open-label, single-treatment, single-period, single dose, clinical phase 1 study to assess the safety and tolerability of Diphtheria, Tetanus, Pertussis (whole cell), Hepatitis B (rDNA) and Haemophilus type B conjugate vaccine (adsorbed) I.P. of M/S Cadila healthcare Ltd., India in healthy, adult, male, human subjects.
Latest Information Update: 31 Aug 2016
At a glance
- Drugs Diphtheria vaccine (Primary) ; Haemophilus vaccines (Primary) ; Hepatitis B vaccine (Primary) ; Pertussis vaccine (Primary) ; Tetanus vaccine (Primary)
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus
- Focus Adverse reactions
- Sponsors Zydus Lifesciences
- 31 Aug 2016 New trial record